Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

10.51
-0.8400-7.40%
Volume:690.44K
Turnover:7.35M
Market Cap:179.78M
PE:-2.72
High:11.20
Open:11.20
Low:10.34
Close:11.35
52wk High:16.77
52wk Low:10.34
Shares:17.11M
Float Shares:15.72M
Volume Ratio:1.47
T/O Rate:4.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.84
PE(LYR):-3.29

Loading ...

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

GlobeNewswire
·
Yesterday

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

GlobeNewswire
·
Sep 08

Adarx Files for US IPO Backed by OrbiMed and Bain Capital

Stock News
·
Sep 05

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

GlobeNewswire
·
Sep 04

Atrium Therapeutics to Present at Wells Fargo Annual Healthcare Conference

Reuters
·
Sep 02

ProQR to Participate in Upcoming Investor Conferences in September 2026

GlobeNewswire
·
Sep 02

Circio boosts circVec gene therapy data and secures funding runway to 2030

TIPRANKS
·
Sep 01

Korro to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 27

Circio bolsters board as it advances circular RNA gene therapy platform

TIPRANKS
·
Aug 26

Press Release: Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and Eur40.25 Million PIPE Financing from New and Existing Investors

Dow Jones
·
Aug 24

BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now

TIPRANKS
·
Aug 22

Brii Biosciences Narrows Interim Loss as HBV and RNA Pipelines Advance

TIPRANKS
·
Aug 21

Atrium Therapeutics Awards New Hire Stock Options for 11,000 Shares at $13.48 Each

Reuters
·
Aug 21

Atrium Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

One Nation staffer allegedly assaulted at major Australian show‘They were spat on. They were punched.’3 min read

7NEWS
·
Aug 17

Atrium Therapeutics Price Target Maintained with a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 15

The huge change set to reshape a beloved Australian traditionNew arenas, homes and facilities are coming to a historic precinct with a 150-year legacy.3 min read

7NEWS
·
Aug 15

Atrium Therapeutics, Inc. (RNA) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Heart Drug Developer Atrium Therapeutics' Q2 Loss Widens as Expenses Rise

Reuters
·
Aug 14